Hunter Johnson, DO
Family Medicine · Antioch, TNNPI 1295230183
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 1,126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 55 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,126 payments — averaging $22.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$5K
- Bayer$3K
- AstraZeneca$2K
- AbbVie$1K
- Amgen$1K
- Lilly USA, LLC$1K
- plus $12K from 49 others
What the payments were for
- Consulting fees$8894%
- Food & beverage$24,26796%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$1,331
- BREZTRI$511
- AIRSUPRA$408
- iLet Bionic Pancreas$405
- FARXIGA$387
- EVENITY$374
- RYBELSUS$365
- Ozempic$347
- Wegovy$243
- Auvelity$239
- CeQur Simplicity$177
- SPRAVATO$147
- The Cologuard Plus Collection Kit$125
- Cologuard Collection Kit$123
- Symbravo$122
- VRAYLAR$121
- CAPLYTA$118
- Omnipod$114
- VOQUEZNA$114
- FASENRA$107
How this compares
$25,156 in reported general payments places this provider in the 95th percentile of 2,087 family medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 188 | $225,251 |
| OzempicSemaglutide | 135 | $165,688 |
| RybelsusSemaglutide | 60 | $125,778 |
| JardianceEmpagliflozin | 83 | $98,038 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 96 | $84,708 |
| KerendiaFinerenone | 47 | $69,634 |
| MounjaroTirzepatide | 24 | $29,577 |
| VraylarCariprazine Hcl | 18 | $25,661 |
| RexultiBrexpiprazole | 14 | $20,151 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $14,917 |
| GemtesaVibegron | 17 | $14,745 |
| EntrestoSacubitril/Valsartan | 15 | $14,739 |
| EliquisApixaban | 11 | $14,717 |
| JanuviaSitagliptin Phosphate | 13 | $12,475 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $9,043 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $4,759 | $291,466195 claims |
| AstraZenecaFarxiga | $1,614 | $225,251188 claims |
| Boehringer IngelheimJardiance, Tradjenta | $662 | $104,74295 claims |
| GSKTrelegy Ellipta | $715 | $84,70896 claims |
| BayerKerendia | $2,599 | $69,63447 claims |
| Lilly USA, LLCMounjaro | $1,101 | $29,57724 claims |
| AbbVieVraylar, Synthroid | $1,498 | $26,65129 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $882 | $20,15114 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $295 | $14,74517 claims |
| NovartisEntresto | $818 | $14,73915 claims |
| PfizerEliquis | $874 | $14,71711 claims |
| MerckJanuvia | $336 | $12,47513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Antioch
- Khaisha GistAntioch$49K
- Christopher HollowayAntioch$41K
- Meredith SchweitzerAntioch$37K
- Kevin DennisFranklin$354K
- Charolette JacksonBartlett$162K
- Keren HolmesNashville$58K
- Kabir Harricharan SinghNewport$49K
- Jerry PunchKnoxville$45K
- Curtis JantziKingsport$39K
- Ellen ClelandChattanooga$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.